Dialysis Market Size to Record 7.9% CAGR Over 2024-2032; Increased Access to Hemodialysis Centers to Accelerate Market Growth

The global dialysis market size touched USD 95.22 billion in 2023 and is predicted to reach USD 98.51 billion in 2024. The market is anticipated to touch USD 181.16 billion by 2032, recording a CAGR of 7.9% over 2024-2032.

Fortune Business Insights™ presents this information in its latest report titled “Dialysis Market Size, Share & COVID-19 Impact Analysis, By Type (Products and Services), By Dialysis Type (Hemodialysis and Peritoneal Dialysis), By End User (Dialysis Centers & Hospitals and Home Care), and Regional Forecast, 2024-2032”.

Dialysis treatments are used to treat patients suffering from renal disorders, such as Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD). The prevalence of these ailments is on the rise across the globe, which has increased the number of patients visiting renal clinics considerably. This scenario has prompted key market players to introduce novel products and services to cater to the medical needs of various patients, which is expected to fuel the dialysis market growth.

COVID-19 Decelerated Market Growth Due to Postponement of Kidney-Related Treatments

The COVID-19 outbreak had a negative influence on the market development as the number of kidney-related procedures went down during this period. The travel and movement restrictions imposed by governments across the world forced many renal care clinics to close down their operations temporarily, compelling patients to postpone their treatments. These factors further decreased the demand for dialysis products and solutions.

Increased Access to Hemodialysis Centers to Accelerate Market Growth

The number of people suffering from Chronic Kidney Disease (CKD) is increasing at a considerable rate across the globe. This factor has boosted the demand for efficient renal care facilities that can reduce patients’ waiting time. Moreover, governments are taking various steps to increase people’s access to hemodialysis centers to fulfill the need for renal care in developing countries, such as India, Mexico, and China. Such initiatives are predicted to accelerate the market progress.

However, risks and complications associated with the procedure is expected to hamper the market growth.

DaVita Inc. Collaborated With Medtronic to Launch New Company Mozarc Medical

DaVita Inc. announced its collaboration with Medtronic to form a new company named Mozarc Medical that will focus on kidney health. Mozarc Medical will focus on enhancing patient’s kidney health by providing state-of-the-art patient-centric technologies and solutions.

Key Companies to Launch Novel Products to Increase Market Presence

Some of the key organizations operating in the market include Baxter, Fresenius Medical Care, and DaVita Inc. These companies are holding a sizeable share of the global market. They are adopting various strategies including increasing their geographical presence through collaborations and partnerships and growing focus on obtaining regulatory approvals for their new products. They are also introducing new products to solidify their market dominance.

Notable Industry Development:

June 2023:  NephroPlus, an Indian dialysis service provider, launched a cutting-edge container dialysis unit in partnership with Shri Vamshi Hospital. The new launch was aimed at offering real-time consultation, monitoring, and other related services and solutions to patients undergoing kidney-related treatments.

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/dialysis-market-102367

List of the Companies Profiled in the Report:

• Baxter (U.S.)


• B Braun SE (Germany)


• Fresenius Medical Care AG & Co. KGaA (Germany)


• Medtronic (Ireland)


• DaVita Inc. (U.S.)


• NIPRO (Japan)


• Asahi Kasei Medical Co., Ltd. (Asahi Kasei Corporation) (Japan)


• Diaverum (Sweden)


• Kimal (U.K.)


• BD (U.S.)

Further Report Findings

• North America dominated the global dialysis market share in 2022 and might remain dominant in the coming years as well due to the increasing number of patients being diagnosed with CKD and End-Stage Renal Disease (ESRD) in the U.S. and Canada.


• The market in Asia Pacific might record a relatively higher growth rate in the global during the forecast period as many public sector organizations are funding various initiatives to ease patients’ access to renal care.


• The dialysis services segment accounted for the largest share of the global market in 2022. The segment’s rapid growth is due to the establishment of well-equipped renal care clinics across the world to treat acute and chronic cases of renal failure. The growing burden of kidney-related diseases will also help the segment grow at a commendable pace.

Table of Segmentation